Data / Form D filings / AbbVie Inc.
AbbVie Inc.: Form D filing
AbbVie Inc., a pharmaceuticals company in North Chicago, IL, filed a Form D with the SEC in 2016. The latest, on May 9, 2016, reports $3.80 billion sold of a $3.80 billion offering to 39 investors.
Find out what AbbVie Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1 North Waukegan Road, North Chicago, IL, 60064
- Phone
- (847) 932-7900
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2012
- Revenue range
- Over $100,000,000
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1551152
The full lists. Form D filings in Illinois: 1,511 rows, $75.55, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 9, 2016 | New notice | $3,800,000,000 | $3,800,000,000 | $0 | 39 | Apr 25, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Thomas A. Hurwich | Executive Officer | |
| Edward M. Liddy | Director | |
| Timothy J. Richmond | Executive Officer | |
| Glenn F. Tilton | Director | |
| Henry E. Gosebruch | Executive Officer | |
| Azita J. Saleki-Gerhardt | Executive Officer | |
| Roxanne S. Austin | Director | |
| Michael E. Severino | Executive Officer | |
| Frederick H. Waddell | Director | |
| William J. Chase | Executive Officer | |
| Richard A. Gonzalez | Executive Officer, Director | |
| Robert J. Alpern | Director | |
| William H.L. Burnside | Director | |
| Brett J. Hart | Director | |
| Carlos E. Alban | Executive Officer | |
| Edward J. Rapp | Director | |
| Laura J. Schumacher | Executive Officer |
Every Form D from the week of May 9, 2016 · All recent filings in Illinois · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what AbbVie Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.